SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Sep-20 6:04 PM View: | Protara Therapeutics, Inc. (TARA) | 14-Sep-20 | Market Sale | 2,554 | $19.40 | $49,540.80 | (< 1%) 588.15K to 585.6K | 56% |
14-Sep-20 4:37 PM View: | Protara Therapeutics, Inc. (TARA) | 10-Sep-20 | Market Sale | 239 | $18.00 | $4,302.00 | (< 1%) 588.39K to 588.15K | 52% |
10-Sep-20 3:58 PM View: | Protara Therapeutics, Inc. (TARA) | 09-Sep-20 | Market Sale | 10,222 | $18.66 | $190,766.00 | (2%) 598.62K to 588.39K | 54% |
10-Sep-20 3:58 PM View: | Protara Therapeutics, Inc. (TARA) | 08-Sep-20 | Market Sale | 3,108 | $18.94 | $58,865.50 | (< 1%) 601.72K to 598.62K | 55% |
04-Sep-20 4:39 PM View: | Protara Therapeutics, Inc. (TARA) | 03-Sep-20 | Market Sale | 52 | $20.19 | $1,049.88 | (< 1%) 601.77K to 601.72K | 57% |
04-Sep-20 4:39 PM View: | Protara Therapeutics, Inc. (TARA) | 02-Sep-20 | Market Sale | 207 | $20.68 | $4,280.76 | (< 1%) 601.98K to 601.77K | 58% |
01-Sep-20 4:53 PM View: | Protara Therapeutics, Inc. (TARA) | 28-Aug-20 | Market Sale | 771 | $22.09 | $17,031.40 | (< 1%) 602.75K to 601.98K | 61% |
28-Aug-20 3:56 PM View: | Protara Therapeutics, Inc. (TARA) | 27-Aug-20 | Market Sale | 616 | $22.37 | $13,779.90 | (< 1%) 603.37K to 602.75K | 62% |
28-Aug-20 3:56 PM View: | Protara Therapeutics, Inc. (TARA) | 26-Aug-20 | Market Sale | 1,418 | $22.40 | $31,763.20 | (< 1%) 604.79K to 603.37K | 62% |
26-Aug-20 4:27 PM View: | Protara Therapeutics, Inc. (TARA) | 25-Aug-20 | Market Sale | 2,461 | $22.73 | $55,938.50 | (< 1%) 607.25K to 604.79K | 62% |
26-Aug-20 4:27 PM View: | Protara Therapeutics, Inc. (TARA) | 24-Aug-20 | Market Sale | 974 | $23.16 | $22,557.80 | (< 1%) 608.22K to 607.25K | 63% |
24-Aug-20 9:51 AM View: | Protara Therapeutics, Inc. (TARA) | 20-Aug-20 | Market Sale | 510 | $24.18 | $12,333.30 | (< 1%) 608.73K to 608.22K | 64% |
20-Aug-20 4:18 PM View: | Protara Therapeutics, Inc. (TARA) | 18-Aug-20 | Market Sale | 200 | $25.19 | $5,038.00 | (< 1%) 608.93K to 608.73K | 66% |
18-Aug-20 5:48 PM View: | Protara Therapeutics, Inc. (TARA) | 17-Aug-20 | Market Sale | 1,548 | $25.11 | $38,870.30 | (< 1%) 610.48K to 608.93K | 66% |
18-Aug-20 5:48 PM View: | Protara Therapeutics, Inc. (TARA) | 14-Aug-20 | Market Sale | 700 | $25.09 | $17,563.00 | (< 1%) 611.18K to 610.48K | 66% |
31-Jul-20 4:59 PM View: | Protara Therapeutics, Inc. (TARA) | 30-Jul-20 | Market Sale | 1,317 | $26.14 | $34,426.40 | (< 1%) 612.5K to 611.18K | 67% |
31-Jul-20 4:59 PM View: | Protara Therapeutics, Inc. (TARA) | 29-Jul-20 | Market Sale | 2,516 | $26.42 | $66,483.50 | (< 1%) 615.01K to 612.5K | 67% |
29-Jul-20 4:40 PM View: | Protara Therapeutics, Inc. (TARA) | 28-Jul-20 | Market Sale | 25,597 | $30.54 | $781,797.00 | (4%) 640.61K to 615.01K | 72% |
29-Jul-20 4:40 PM View: | Protara Therapeutics, Inc. (TARA) | 27-Jul-20 | Market Sale | 338 | $26.08 | $8,815.04 | (< 1%) 640.95K to 640.61K | 67% |
27-Jul-20 4:07 PM View: | Protara Therapeutics, Inc. (TARA) | 24-Jul-20 | Market Sale | 300 | $26.00 | $7,800.00 | (< 1%) 641.25K to 640.95K | 67% |
27-Jul-20 4:07 PM View: | Protara Therapeutics, Inc. (TARA) | 23-Jul-20 | Market Sale | 2,043 | $26.61 | $54,369.00 | (< 1%) 643.29K to 641.25K | 68% |
23-Jul-20 4:31 PM View: | Protara Therapeutics, Inc. (TARA) | 22-Jul-20 | Market Sale | 1,372 | $26.73 | $36,675.30 | (< 1%) 644.66K to 643.29K | 68% |
23-Jul-20 4:31 PM View: | Protara Therapeutics, Inc. (TARA) | 21-Jul-20 | Market Sale | 223 | $26.56 | $5,922.88 | (< 1%) 644.89K to 644.66K | 68% |
21-Jul-20 4:44 PM View: | Protara Therapeutics, Inc. (TARA) | 20-Jul-20 | Market Sale | 2,729 | $26.87 | $73,326.90 | (< 1%) 647.62K to 644.89K | 68% |
21-Jul-20 4:44 PM View: | Protara Therapeutics, Inc. (TARA) | 17-Jul-20 | Market Sale | 1,601 | $26.66 | $42,682.70 | (< 1%) 649.22K to 647.62K | 68% |
14-Jul-20 4:40 PM View: | Protara Therapeutics, Inc. (TARA) | 13-Jul-20 | Market Sale | 2,145 | $27.13 | $58,193.80 | (< 1%) 651.36K to 649.22K | 68% |
14-Jul-20 4:40 PM View: | Protara Therapeutics, Inc. (TARA) | 10-Jul-20 | Market Sale | 2,659 | $27.41 | $72,883.20 | (< 1%) 654.02K to 651.36K | 69% |
13-Jan-20 6:59 PM View: | Protara Therapeutics, Inc. (TARA) | 09-Jan-20 | Grant | 654,020 | -- | -- | 100% 0 to 654.02K |